Screener
Chemours CC Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Chemours in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Chemours’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 11:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001627223-26-000024
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Treasury stock, at cost (48,813,294 shares at June 30, 2026 and 48,826,793 at December 31, 2025) | (1,801) | (1,802) |
| Additional paid-in capital | 1,088 | 1,074 |
| Retained earnings | 891 | 1,220 |
| Accumulated other comprehensive loss | (229) | (244) |
| Total Chemours stockholders’ equity | (49) | 250 |
| Non-controlling interests | 1 | 1 |
| Total equity | (48) | 251 |
| Total liabilities and equity | $7,150 | $7,382 |
Item 1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Chemours's total equity?
- Chemours (CC) reported total equity of -$49M in Q2 2026.
- How has Chemours's total equity changed year-over-year?
- Chemours's total equity decreased by 121.5% year-over-year, from $228M to -$49M.
- What is the long-term trend for Chemours's total equity?
- Over 5 years (2020 to 2025), Chemours's total equity has grown at a -21.0% compound annual growth rate (CAGR), from $813M to $250M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Chemours's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude